Bristol Myers: Can It Shake Off The Blahs?

It's no longer news that pharmaceutical stocks have been pretty sick. Last year was their worst in 20 years, and they're still ailing, based on the group's dismal performance so far. The big fear now is that President Clinton will impose curbs on drug prices. So Street pros have been avoiding pharmaceuticals like the plague.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.